Trial Information

Summary: Patients with Skin Spots, Skin Discolorations, Discolored Patches of Skin needed for a clinical research trial.

A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multiple-Site Study To Evaluate the Clinical Equivalence Of Two Ketoconazole 2% Shampoos In Patients with Tinea (Pityriasis) Versicolor.

Study visits include a screening visit and 2 office visits over 1 month.

Major Inclusion Criteria:

  • Male or non-pregnant, non-lactating females 18 years of age or older
  • Clinical signs and symptoms of tinea versicolor

As part of the study, you will receive at no cost:

  • Study-related medical care and exams
  • Study-related drug or placebo
  • Compensation up to $150.00 for time and travel

For more information,

Contact:

Silvia Sanchez, Patient Recruitment Coordinator
Advanced Clinical Research Institute (ACRI)
1211 W. La Palma Ave., Suite 602
Anaheim, CA 92801
Telephone: 714-778-1309 x227
Fax: 714-778-0667
Email:

Profile Page: Advanced Clinical Research Institute (ACRI), Anaheim, CA

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:35 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA